Radiofrequency ablation is safe in patients with hepatocellular carcinoma and thrombocytopenia
Abdominal Radiology · 01.08.2025 · 51 (3) · 1325-1331
DOI: 10.1007/s00261-025-05121-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 01.08.2025. Verfasst von Songchi Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China. xiao_songchi@wchscu.cn. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Thrombocytopenia, Radiofrequency Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This study aims to evaluate the safety and efficacy of radiofrequency ablation (RFA) in cirrhotic patients with hepatocellular carcinoma (HCC) and severe thrombocytopenia (platelet count 30 × 10⁹/L for this high-risk population. CLINICAL SIGNIFICANCE: RFA demonstrates high efficacy and safety in cirrhotic patients with HCC, even those with severe thrombocytopenia ( 30 × 10⁹/L) but also expand therapeutic options for this high-risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China. xiao_songchi@wchscu.cn.
- Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, China. xiao_songchi@wchscu.cn.
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
- Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, China.
- Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China. luo_xuefeng@wchscu.cn.
- Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, West China Hospital, Sichuan University, Chengdu, China. luo_xuefeng@wchscu.cn.
Zitieren
APA
Xiao, S., Wang, X., & Luo, X. (2025). Radiofrequency ablation is safe in patients with hepatocellular carcinoma and thrombocytopenia. Abdominal Radiology, 51(3), 1325-1331. https://doi.org/10.1007/s00261-025-05121-5
Vancouver
Xiao S, Wang X, Luo X. Radiofrequency ablation is safe in patients with hepatocellular carcinoma and thrombocytopenia. Abdominal Radiology. 2025;51(3):1325-1331. doi:10.1007/s00261-025-05121-5
BibTeX
@article{Xiao2025,
author = {Xiao, Songchi and Wang, Xiaoze and Luo, Xuefeng},
title = {Radiofrequency ablation is safe in patients with hepatocellular carcinoma and thrombocytopenia},
journal = {Abdominal Radiology},
year = {2025},
volume = {51},
number = {3},
pages = {1325--1331},
doi = {10.1007/s00261-025-05121-5}
}
EUVIMED